H1R expression by CD11B+ cells is not required for susceptibility to experimental allergic encephalomyelitis

Cellular Immunology

Volumn 278, Issue 1-2, 2012, Pages 27-34

  Saligrama, Naresha ^a   Noubade, Rajkumar ^a   Case, Laure K ^a   Poynter, Matthew E ^a   Teuscher, Cory ^a,b,c  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF VERMONT   (United States)

^c University of Houston   (United States)

Author keywords

Antigen presenting cells; Experimental allergic encephalomyelitis; Histamine H1 receptor; Multiple sclerosis

Indexed keywords

CD11B ANTIGEN; HISTAMINE H1 RECEPTOR;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CD11B+ CELL; CELL SPECIFICITY; CYTOKINE RELEASE; DISEASE PREDISPOSITION; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD1; CYTOKINES; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GENE EXPRESSION; GENETIC PREDISPOSITION TO DISEASE; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MULTIPLE SCLEROSIS; ORGAN SPECIFICITY; RECEPTORS, HISTAMINE H1; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

MUS;

EID: 84868273635     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2012.06.012     Document Type: Article

References (59)

1. Gandhi R., Laroni A., Weiner H.L. Role of the innate immune system in the pathogenesis of multiple sclerosis. J. Neuroimmunol. 2010, 221:7-14.
2. Zozulya A.L., Clarkson B.D., Ortler S., Fabry Z., Wiendl H. The role of dendritic cells in CNS autoimmunity. J. Mol. Med. (Berlin) 2010, 88:535-544.
3. Steinman R.M. Dendritic cells: understanding immunogenicity. Eur. J. Immunol. 2007, 37(Suppl. 1):S53-S60.
4. Yamazaki S., Iyoda T., Tarbell K., Olson K., Velinzon K., Inaba K., Steinman R.M. Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells. J. Exp. Med. 2003, 198:235-247.
5. Yamazaki S., Patel M., Harper A., Bonito A., Fukuyama H., Pack M., Tarbell K.V., Talmor M., Ravetch J.V., Inaba K., Steinman R.M. Effective expansion of alloantigen-specific Foxp3+ CD25+ CD4+ regulatory T cells by dendritic cells during the mixed leukocyte reaction. Proc. Natl. Acad. Sci. USA 2006, 103:2758-2763.
6. Tarbell K.V., Yamazaki S., Olson K., Toy P., Steinman R.M. CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J. Exp. Med. 2004, 199:1467-1477.
7. Comabella M., Montalban X., Munz C., Lunemann J.D. Targeting dendritic cells to treat multiple sclerosis. Nat. Rev. Neurol. 2010, 6:499-507.
8. Greenstein J.I. Current concepts of the cellular and molecular pathophysiology of multiple sclerosis. Dev. Neurobiol. 2007, 67:1248-1265.
9. Karni A., Abraham M., Monsonego A., Cai G., Freeman G.J., Hafler D., Khoury S.J., Weiner H.L. Innate immunity in multiple sclerosis: myeloid dendritic cells in secondary progressive multiple sclerosis are activated and drive a proinflammatory immune response. J. Immunol. 2006, 177:4196-4202.
10. Huang Y.M., Xiao B.G., Ozenci V., Kouwenhoven M., Teleshova N., Fredrikson S., Link H. Multiple sclerosis is associated with high levels of circulating dendritic cells secreting pro-inflammatory cytokines. J. Neuroimmunol. 1999, 99:82-90.
11. Vaknin-Dembinsky A., Balashov K., Weiner H.L. IL-23 is increased in dendritic cells in multiple sclerosis and down-regulation of IL-23 by antisense oligos increases dendritic cell IL-10 production. J. Immunol. 2006, 176:7768-7774.
12. Vaknin-Dembinsky A., Murugaiyan G., Hafler D.A., Astier A.L., Weiner H.L. Increased IL-23 secretion and altered chemokine production by dendritic cells upon CD46 activation in patients with multiple sclerosis. J. Neuroimmunol. 2008, 195:140-145.
13. Warren K.G., Catz I., Ferenczi L.Z., Krantz M.J. Intravenous synthetic peptide MBP8298 delayed disease progression in an HLA Class II-defined cohort of patients with progressive multiple sclerosis: results of a 24-month double-blind placebo-controlled clinical trial and 5years of follow-up treatment. Eur. J. Neurol. 2006, 13:887-895.
14. del Pilar Martin M., Cravens P.D., Winger R., Frohman E.M., Racke M.K., Eagar T.N., Zamvil S.S., Weber M.S., Hemmer B., Karandikar N.J., Kleinschmidt-DeMasters B.K., Stuve O. Decrease in the numbers of dendritic cells and CD4+ T cells in cerebral perivascular spaces due to natalizumab. Arch. Neurol. 2008, 65:1596-1603.
15. Simon T., Laszlo V., Falus A. Impact of histamine on dendritic cell functions. Cell Biol. Int. 2011, 35:997-1000.
16. Akdis C.A., Simons F.E. Histamine receptors are hot in immunopharmacology. Eur. J. Pharmacol. 2006, 533:69-76.
17. Baron J.L., Madri J.A., Ruddle N.H., Hashim G., Janeway C.A. Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma. J. Exp. Med. 1993, 177:57-68.
18. Tanaka S., Deai K., Konomi A., Takahashi K., Yamane H., Sugimoto Y., Ichikawa A. Expression of L-histidine decarboxylase in granules of elicited mouse polymorphonuclear leukocytes. Eur. J. Immunol. 2004, 34:1472-1482.
19. Logothetis L., Mylonas I.A., Baloyannis S., Pashalidou M., Orologas A., Zafeiropoulos A., Kosta V., Theoharides T.C. A pilot, open label, clinical trial using hydroxyzine in multiple sclerosis. Int. J. Immunopathol. Pharmacol. 2005, 18:771-778.
20. Gregory G.D., Bickford A., Robbie-Ryan M., Tanzola M., Brown M.A. MASTering the immune response: mast cells in autoimmunity. Novartis Found. Symp. 2005, 271:215-225. (discussion 225-231).
21. Pollack I., Hofbauer A. Histamine-like immunoreactivity in the visual system and brain of Drosophila melanogaster. Cell Tissue Res. 1991, 266:391-398.
22. Shiraishi M., Hirasawa N., Oikawa S., Kobayashi Y., Ohuchi K. Analysis of histamine-producing cells at the late phase of allergic inflammation in rats. Immunology 2000, 99:600-606.
23. Leurs R., Smit M.J., Timmerman H. Molecular pharmacological aspects of histamine receptors. Pharmacol. Ther. 1995, 66:413-463.
24. Yokoyama M., Yokoyama A., Mori S., Takahashi H.K., Yoshino T., Watanabe T., Ohtsu H., Nishibori M. Inducible histamine protects mice from P. acnes-primed and LPS-induced hepatitis through H2-receptor stimulation. Gastroenterology 2004, 127:892-902.
25. Alonso A., Jick S.S., Hernan M.A. Allergy, histamine 1 receptor blockers, and the risk of multiple sclerosis. Neurology 2006, 66:572-575.
26. El Behi M., Dubucquoi S., Lefranc D., Zephir H., De Seze J., Vermersch P., Prin L. New insights into cell responses involved in experimental autoimmune encephalomyelitis and multiple sclerosis. Immunol. Lett. 2005, 96:11-26.
27. Theoharides T.C., Cochrane D.E. Critical role of mast cells in inflammatory diseases and the effect of acute stress. J. Neuroimmunol. 2004, 146:1-12.
28. Bebo B.F., Yong T., Orr E.L., Linthicum D.S. Hypothesis: a possible role for mast cells and their inflammatory mediators in the pathogenesis of autoimmune encephalomyelitis. J. Neurosci. Res. 1996, 45:340-348.
29. Hofstra C.L., Desai P.J., Thurmond R.L., Fung-Leung W.P. Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells. J. Pharmacol. Exp. Ther. 2003, 305:1212-1221.
30. Lu C., Diehl S.A., Noubade R., Ledoux J., Nelson M.T., Spach K., Zachary J.F., Blankenhorn E.P., Teuscher C. Endothelial histamine H1 receptor signaling reduces blood-brain barrier permeability and susceptibility to autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 2010, 107:18967-18972.
31. Caron G., Delneste Y., Roelandts E., Duez C., Bonnefoy J.Y., Pestel J., Jeannin P. Histamine polarizes human dendritic cells into Th2 cell-promoting effector dendritic cells. J. Immunol. 2001, 167:3682-3686.
32. O'Mahony L., Akdis M., Akdis C.A. Regulation of the immune response and inflammation by histamine and histamine receptors. J. Allergy Clin. Immunol. 2011, 128:1153-1162.
33. Pavlinkova G., Yanagawa Y., Kikuchi K., Iwabuchi K., Onoe K. Effects of histamine on functional maturation of dendritic cells. Immunobiology 2003, 207:315-325.
34. Szeberenyi J.B., Laszlo V., Pallinger E., Orso E., Rothe G., Schmitz G., Falus A. Intracellular histamine content increases during in vitro dendritic cell differentiation. Inflamm. Res. 2001, 50(Suppl 2):S112-113.
35. Mazzoni A., Young H.A., Spitzer J.H., Visintin A., Segal D.M. Histamine regulates cytokine production in maturing dendritic cells, resulting in altered T cell polarization. J. Clin. Invest. 2001, 108:1865-1873.
36. Jutel M., Watanabe T., Akdis M., Blaser K., Akdis C.A. Immune regulation by histamine. Curr. Opin. Immunol. 2002, 14:735-740.
37. Vanbervliet B., Akdis M., Vocanson M., Rozieres A., Benetiere J., Rouzaire P., Akdis C.A., Nicolas J.F., Hennino A. Histamine receptor H1 signaling on dendritic cells plays a key role in the IFN-gamma/IL-17 balance in T cell-mediated skin inflammation. J. Allergy Clin. Immunol. 2011, 127:943-953. and 941-910.
38. Beller D.I., Springer T.A., Schreiber R.D. Anti-Mac-1 selectively inhibits the mouse and human type three complement receptor. J. Exp. Med. 1982, 156:1000-1009.
39. Rosmarin A.G., Weil S.C., Rosner G.L., Griffin J.D., Arnaout M.A., Tenen D.G. Differential expression of CD11b/CD18 (Mo1) and myeloperoxidase genes during myeloid differentiation. Blood 1989, 73:131-136.
40. Anjuere F., Martin P., Ferrero I., Fraga M.L., del Hoyo G.M., Wright N., Ardavin C. Definition of dendritic cell subpopulations present in the spleen, Peyer's patches, lymph nodes, and skin of the mouse. Blood 1999, 93:590-598.
41. Schwartz J.C., Arrang J.M., Garbarg M., Pollard H., Ruat M. Histaminergic transmission in the mammalian brain. Physiol. Rev. 1991, 71:1-51.
42. Claiborne B.J., Selverston A.I. Histamine as a neurotransmitter in the stomatogastric nervous system of the spiny lobster. J. Neurosci. 1984, 4:708-721.
43. Stuart A.E. From fruit flies to barnacles, histamine is the neurotransmitter of arthropod photoreceptors. Neuron 1999, 22:431-433.
44. Gisselmann G., Plonka J., Pusch H., Hatt H. Unusual functional properties of homo- and heteromultimeric histamine-gated chloride channels of Drosophila melanogaster: spontaneous currents and dual gating by GABA and histamine. Neurosci. Lett. 2004, 372:151-156.
45. McCaman R.E., Weinreich D. Histaminergic synaptic transmission in the cerebral ganglion of Aplysia. J. Neurophysiol. 1985, 53:1016-1037.
46. Farrant M., Kaila K. The cellular, molecular and ionic basis of GABA(A) receptor signalling. Prog. Brain Res. 2007, 160:59-87.
47. del Rio R., Noubade R., Saligrama N., Wall E.H., Krementsov D.N., Poynter M.E., Zachary J.F., Thurmond R.L., Teuscher C. Histamine H4 receptor optimizes T regulatory cell frequency and facilitates anti-inflammatory responses within the central nervous system. J. Immunol. 2012, 188:541-547.
48. Jutel M., Watanabe T., Klunker S., Akdis M., Thomet O.A., Malolepszy J., Zak-Nejmark T., Koga R., Kobayashi T., Blaser K., Akdis C.A. Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors. Nature 2001, 413:420-425.
49. Noubade R., Milligan G., Zachary J.F., Blankenhorn E.P., del Rio R., Rincon M., Teuscher C. Histamine receptor H1 is required for TCR-mediated p38 MAPK activation and optimal IFN-gamma production in mice. J. Clin. Invest. 2007, 117:3507-3518.
50. Holman D.W., Klein R.S., Ransohoff R.M. The blood-brain barrier, chemokines and multiple sclerosis. Biochim. Biophys. Acta 1812, 2011:220-230.
51. O'Connor K.C., Bar-Or A., Hafler D.A. The neuroimmunology of multiple sclerosis: possible roles of T and B lymphocytes in immunopathogenesis. J. Clin. Immunol. 2001, 21:81-92.
52. Zuvich R.L., McCauley J.L., Pericak-Vance M.A., Haines J.L. Genetics and pathogenesis of multiple sclerosis. Semin. Immunol. 2009, 21:328-333.
53. Meeker N.D., Stafford A.N., Lunceford J.K., Avner P., Ma R.Z., Teuscher C. Physical mapping of the autoimmune disease susceptibility locus, Bphs: co-localization with a cluster of genes from the TNF receptor superfamily on mouse chromosome 6. Mamm. Genome 1999, 10:858-863.
54. Sudweeks J.D., Todd J.A., Blankenhorn E.P., Wardell B.B., Woodward S.R., Meeker N.D., Estes S.S., Teuscher C. Locus controlling Bordetella pertussis-induced histamine sensitization (Bphs), an autoimmune disease-susceptibility gene, maps distal to T-cell receptor beta-chain gene on mouse chromosome 6. Proc. Natl. Acad. Sci. USA 1993, 90:3700-3704.
55. Teuscher C. Experimental allergic orchitis in mice. II. Association of disease susceptibility with the locus controlling Bordetella pertussis-induced sensitivity to histamine. Immunogenetics 1985, 22:417-425.
56. Ben-Nun A., Wekerle H., Cohen I.R. The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis. Eur. J. Immunol. 1981, 11:195-199.
57. McFarland H.F., Martin R. Multiple sclerosis: a complicated picture of autoimmunity. Nat. Immunol. 2007, 8:913-919.
58. Oksenberg J.R., Baranzini S.E., Sawcer S., Hauser S.L. The genetics of multiple sclerosis: SNPs to pathways to pathogenesis. Nat. Rev. Genet. 2008, 9:516-526.
59. Steinman R.M. Dendritic cells in vivo: a key target for a new vaccine science. Immunity 2008, 29:319-324.